These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15929860)

  • 21. ["No infarct without elevated LDL cholesterol"!].
    Greten H
    MMW Fortschr Med; 2008 Nov; 150(48):119. PubMed ID: 19125517
    [No Abstract]   [Full Text] [Related]  

  • 22. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 23. Maximum Low-density Lipoprotein Cholesterol Lowering Capacity Achievable With Drug Combinations. When 50 Plus 20 Equals 60.
    Masana L; Ibarretxe D; Plana N
    Rev Esp Cardiol (Engl Ed); 2016 Mar; 69(3):342-3. PubMed ID: 26856792
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 25. Lipid management with statins. The lower the better?
    Laufs U; Liao JK; Böhm M
    Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lowering LDL cholesterol is good, but how and in whom?
    Stone NJ; Lloyd-Jones DM
    N Engl J Med; 2015 Apr; 372(16):1564-5. PubMed ID: 25773740
    [No Abstract]   [Full Text] [Related]  

  • 27. [ANMCO Position paper: Clinical management of hypercholesterolemia in patients with acute coronary syndrome].
    Colivicchi F; Gulizia MM; Arca M; Abrignani MG; Perna GP; Mureddu GF; Nardi F; Riccio C;
    G Ital Cardiol (Rome); 2016 Jun; 17(6):456-61. PubMed ID: 27311088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 29. The statin era: in search of the ideal lipid regulating agent.
    Shepherd J
    Heart; 2001 Mar; 85(3):259-64. PubMed ID: 11179260
    [No Abstract]   [Full Text] [Related]  

  • 30. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?
    Athyros VG; Tziomalos K; Karagiannis A; Wierzbicki AS; Mikhailidis DP
    Curr Opin Cardiol; 2010 Jul; 25(4):406-10. PubMed ID: 20375883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PCSK9 Inhibitors and Cardiovascular Events.
    Goemann IM; Londero TM; Dora JM
    N Engl J Med; 2015 Aug; 373(8):773-4. PubMed ID: 26287856
    [No Abstract]   [Full Text] [Related]  

  • 32. PCSK9 Inhibitors and Cardiovascular Events.
    Sabatine MS; Wasserman SM; Stein EA
    N Engl J Med; 2015 Aug; 373(8):774-5. PubMed ID: 26295078
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid parameters and cardiovascular events in patients taking statins.
    Brook RD; Rubenfire M
    JAMA; 2012 Jul; 308(2):132; author reply 132-3. PubMed ID: 22782403
    [No Abstract]   [Full Text] [Related]  

  • 34. Lipid parameters and cardiovascular events in patients taking statins.
    Martin SS; Jones SR
    JAMA; 2012 Jul; 308(2):131-2; author reply 132-3. PubMed ID: 22782402
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
    Klose G
    MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the current debate on lowering LDL cholesterol with ezetimibe].
    Breuer HW
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
    [No Abstract]   [Full Text] [Related]  

  • 37. [Efficacy and safety of statin therapy in old age].
    Klose G; Windler E; Nitschmann S
    Internist (Berl); 2019 Aug; 60(8):878-880. PubMed ID: 31214726
    [No Abstract]   [Full Text] [Related]  

  • 38. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
    März W
    MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of low-density lipoprotein cholesterol lowering by pravastatin to <100 mg/dl versus >100 mg/dl on brachial artery vasoreactivity in patients with severe hypercholesterolemia and previous atherosclerotic events or diabetes mellitus.
    Lekakis JP; Papamichael CM; Barbaki P; Papaioannou TG; Stamatelopoulos KS; Dagre AG; Stamatelopoulos SF
    Am J Cardiol; 2002 Apr; 89(7):857-60. PubMed ID: 11909575
    [No Abstract]   [Full Text] [Related]  

  • 40. PCSK9 inhibitors reduce cardiovascular events, preliminary data show.
    Mayor S
    BMJ; 2015 Mar; 350():h1508. PubMed ID: 25782694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.